| Symbol | IMDX |
|---|---|
| Name | INSIGHT MOLECULAR DIAGNOSTICS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Address | 2 INTERNATIONAL PLAZA DR.,SUITE 510, NASHVILLE, 37217, United States |
| Telephone | +1 949 409-7600 |
| Fax | — |
| — | |
| Website | https://www.oncocyte.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001642380 |
| Description | Insight Molecular Diagnostics Inc., or iMDx (formerly Oncocyte Corporation), is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information. Additional info from NASDAQ: |
(30% Negative) INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX) Reports Q2 2026 Financial Results
Read moreIMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
Read more(99% Neutral) INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX) Provides Business Update
Read moreNew Form DEFA14A - Insight Molecular Diagnostics Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020518 <b>Size:</b> 726 KB
Read moreNew Form DEF 14A - Insight Molecular Diagnostics Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020502 <b>Size:</b> 7 MB
Read moreBROADWOOD PARTNERS, L.P. 🟢 acquired 270.0K shares (2 derivative) of Insight Molecular Diagnostics Inc. (IMDX) at $30.60 ($11.2M) Transaction Date: Apr 23, 2026 | Filing ID: 002414
Read moreNew Form SCHEDULE 13D/A - Insight Molecular Diagnostics Inc. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0000919574-26-002415 <b>Size:</b> 33 KB
Read moreBROADWOOD PARTNERS, L.P. 🟢 acquired 117.3K shares (2 derivative) of Insight Molecular Diagnostics Inc. (IMDX) at $30.60 ($9.8M) Transaction Date: Apr 16, 2026 | Filing ID: 002306
Read moreJames Andrea S. 🟡 adjusted position in 11.3K shares (1 derivative) of Insight Molecular Diagnostics Inc. (IMDX) at $4.11 Transaction Date: Mar 26, 2026 | Filing ID: 013574
Read moreLiu James Yang 🟡 adjusted position in 2.6K shares (1 derivative) of Insight Molecular Diagnostics Inc. (IMDX) at $4.11 Transaction Date: Mar 26, 2026 | Filing ID: 013572
Read more